Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
268 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (46)
  • Closed (156)

Medical Condition

  • Show all (1768)
  • Addiction (18)
  • Allergy, Asthma, & Immunology (13)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (29)
  • Blood Disorders (33)
  • Bone & Muscle (10)
  • Cancer (585)
    • Bladder Cancer (16)
    • Brain Cancer (12)
    • Breast Cancer (65)
    • Gastrointestinal (10)
    • Gynecologic Cancer (30)
    • Head and Neck Cancer (4)
    • Kidney Cancer (7)
    • Leukemia (64)
    • Liver Cancer (5)
    • Lung Cancer (58)
    • Lymphoma (24)
    • Multiple Myeloma (24)
    • Pancreatic Cancer (6)
    • Prostate Cancer (27)
    • Sarcoma (23)
    • Skin Cancer (26)
      • (-) Melanoma (16)
      • Squamous Cell Carcinoma (5)
    • Solid Tumors (36)
    • Thyroid Cancer (1)
    • Uveal Melanoma (7)
  • Child Development (4)
  • COVID-19 (Coronavirus) (36)
  • Critical Illness (1)
  • Diabetes (21)
  • Ear, Nose and Throat (11)
  • Endocrine & Metabolic Disease (12)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (26)
  • Hair and Skin Disorders (3)
  • Headaches (5)
  • (-) Healthy Volunteers (186)
    • Exercise (2)
  • Heart Disease (130)
  • Infectious Disease (48)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (53)
  • Lung Disease (31)
  • Meniere's Disease (1)
  • Neurological Disorders (166)
  • Nutrition (6)
  • Obesity (10)
  • Obstetrics & Gynecology (55)
  • Pain Management (1)
  • Pediatrics (102)
  • Psychiatric Disorders (67)
  • Rehabilitation (8)
  • Stroke (7)
  • Surgery (7)
  • Transplant (47)
  • Urology (4)
  • Vascular Conditions (10)
Displaying 201 - 202 of 202

Study of Encorafenib + Binimetinib in Patients wit hBRAFV600-Mutant Melanoma Brain Metastasis

Condition: Skin Cancer / Melanoma
Investigator: Richard Carvajal, MD
Status: Closed
The purpose of this research study is to determine if high-dose versus standard-dose regimens of encorafenib and binimetinib are safe and have positive effects in people who have melanoma brain metastasis and also have been found by their doctor to have a mutated gene called BRAFV600. The time frame for the study is approximately 2 years.
Read More

IMAGene: A study for healthy volunteers evaluating how genes affect health risks

Condition: Healthy Volunteers
Investigator: Julia Wynn
Status: Closed
This study is evaluating genomic screening in Ashkenazi Jewish and Hispanic communities. Genomic screening is done by collecting a blood sample and looking at a person's genes to learn if they are at high risk for certain health problems like cancer or heart disease or are at risk to have a child with a genetic condition. The study is designed to…
Read More

Pagination

  • Previous page ‹‹
  • Page 2
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science